Treatment
Comparator clinical trials
We’re tracking 1,730 recruiting studies that include Comparator, each written for real people, not researchers, below.
Recruiting studies
- NCT07544576Enrolling by invitationPhase 4
Knee Arthritis Injection: Two Injection Methods Compared
This study compares two ways of injecting a steroid medication into arthritic knees: using landmark guidance (traditional method) with a higher dose versus ultrasound guidance (imaging) with a lower dose. The goal is to see which approach works better to reduce knee pain and improve function.
Ventura, CaliforniaAges 50 years+ - NCT07483788Recruiting
Comparing two materials for infected tooth nerve treatment
This study compares two materials (MTA and Biodentine) used to treat a painful, infected nerve in a back tooth. Instead of a full root canal, the dentist will remove only the top part of the nerve and seal it. The goal is to see which material works better to save your tooth.
Karachi, SindhAges 18–40 - NCT07520500Recruiting
Comparing two surgical techniques for high anal fistula
This trial compares two surgical methods (IFOC and LIFT) for treating high anal fistulas—abnormal tunnels that form near the anus. The goal is to determine which approach works better and has fewer side effects.
Cairo, Al-Manial, Cairo, EgyptAges 18 years+ - NCT07457749RecruitingEarly Phase 1
Comparing two tooth-colored fillings for back teeth cavities
This study tests a new self-hardening filling material against a light-activated bioactive filling for cavities between back teeth. The goal is to see which material works better and lasts longer.
Cairo, El Sherouk CityAges 18–47 - NCT07492576Recruiting
Magnesium shield vs. standard graft for implants
This trial compares two methods for placing dental implants right after removing a failing tooth in the upper front area. It tests whether a magnesium shield helps preserve the bone and gum better than the usual grafting technique.
CairoAges 18–60 - NCT07470736Recruiting
Comparing intubation tools for difficult airways
This trial tests two different ways to help doctors put a breathing tube in a patient with a difficult airway. It compares using a video laryngoscope with a video stylet versus using a video laryngoscope with a fiberoptic scope in a simulated setting.
Kuala Lumpur, Bandar Tun RazakAges Any age - NCT07344727Recruiting
Can haskap berries help you recover after heavy squats?
This study tests whether taking haskap berries (a type of superfruit) before and after intense squat workouts can speed up your recovery and reduce soreness.
Bozeman, MontanaAges 18–35 - NCT07280455Recruiting
Comparing gold vs. steel retainers after braces
This study compares two types of fixed retainers (gold vs. stainless steel) to see which works better after braces are removed. It's for people aged 15–30 who have completed orthodontic treatment and have a well-aligned lower front teeth.
Baghdad, Baghdad GovernorateAges 15–30 - NCT07291336RecruitingPhase 4
Comparing two ways to place dental implants
This trial compares two methods for placing dental implants in the upper jaw: dynamic navigation (real-time guidance) versus static navigation (using a surgical guide). It aims to see which technique is more accurate for people missing one tooth between the right and left second premolars.
CairoAges 22–60 - NCT07239024Enrolling by invitationPhase 1
Comparing two ways to speed up canine tooth movement
This study compares two methods to speed up moving your canine teeth into their correct position after removing the premolars: a small surgical procedure (piezocision) or a natural blood concentrate treatment (injectable platelet-rich fibrin). The goal is to see which method works better for faster, safer tooth movement.
CairoAges 14–22 - NCT07222241Recruiting
Comparing numbing methods for Mohs surgery on face or scalp
This study compares two ways of numbing the skin during Mohs surgery for skin cancer on the face or scalp. It aims to find which method causes less pain and is more satisfying for patients.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07165951RecruitingPhase 3
Study of new drug combo for first treatment of advanced pancreatic cancer
This trial tests a new combination of drugs (TQB2868 injection plus anlotinib capsules) compared to standard chemotherapy for people with pancreatic cancer that has spread to other parts of the body and has not been treated before.
Hefei, AnhuiAges 18–75 - NCT07019077Recruiting
Bleeding risk after stomach or colon procedures on blood thinners
This study compares bleeding after common endoscopic procedures (like colonoscopy or upper endoscopy) between people who take blood thinners and those who don't. It may help doctors better understand risks for patients on anticoagulants.
MilanAges 18 years+ - NCT07701993RecruitingPhase 3
Testing efimosfermin for MASH with compensated cirrhosis
This trial tests whether efimosfermin, an experimental drug, can safely help people with MASH (a fatty liver disease) that has led to cirrhosis (liver scarring) but the liver is still working well (compensated). Participants will be randomly assigned to receive the drug or a placebo.
Miami, FloridaAges 18–75 - NCT06952504RecruitingPhase 3
Comparing two drug combos for advanced endometrial cancer
This trial tests a new drug combination (sacituzumab tirumotecan plus pembrolizumab) against pembrolizumab alone for people with a specific type of advanced or recurrent endometrial cancer that has normal mismatch repair function. It aims to see which treatment works better.
Mobile, AlabamaAges 18 years+ - NCT07532941RecruitingPhase 4
Stopping antibiotics early versus completing the full course
This study compares two ways of giving antibiotics to children: stopping when symptoms feel better versus finishing all the prescribed doses. Researchers want to see if stopping early is safe and works just as well, which could help reduce unnecessary antibiotic use.
Melbourne, VictoriaAges 1–17 - NCT07564141RecruitingPhase 3
New Drug for Recurrent Ovarian Cancer After Chemotherapy
This study tests a new medicine called Rina-S (with or without a blood vessel-blocking drug) compared to standard chemotherapy options for ovarian cancer that has come back after initial treatment. The goal is to see if Rina-S works better and is safer than current standard care.
Danbury, ConnecticutAges 18 years+ - NCT06632327RecruitingPhase 3
Comparing treatment timing for stage II-IIIB lung cancer
This trial is for people with a certain type of lung cancer (non-small cell lung cancer) that can be surgically removed. It tests whether it is better to receive treatment before or after surgery to remove the cancer.
Birmingham, AlabamaAges 18 years+ - NCT07704892RecruitingPhase 3
Study of efimosfermin for adults with cirrhosis from MASH
This trial tests a new drug, efimosfermin, to see if it is safe and effective for people with cirrhosis caused by MASH (a type of fatty liver disease). It may help improve liver health compared to a placebo.
Miami, FloridaAges 18–75 - NCT06872125RecruitingPhase 3
Testing zorevunersen for Dravet syndrome
This study tests an experimental drug called zorevunersen for people with Dravet syndrome. It aims to see if the drug can reduce seizures and improve safety.
Phoenix, ArizonaAges 2–17 - NCT06979362RecruitingPhase 2
Study of CDR132L for heart failure with preserved pumping function
This trial tests if CDR132L can improve heart structure and function in people with a type of heart failure where the heart pumps normally but is stiff and thickened. It may help if you have heart failure with preserved ejection fraction and a thickened heart muscle.
Birmingham, AlabamaAges 40–84 - NCT07623161RecruitingPhase 3
Elritercept versus placebo for myelofibrosis anemia on ruxolitinib
This study tests whether a new drug called elritercept can help reduce the need for blood transfusions in adults with myelofibrosis (a bone marrow cancer) who are already taking ruxolitinib. The goal is to see if elritercept helps your body make more red blood cells naturally.
Glendale, CaliforniaAges 18 years+ - NCT06289478Recruiting
Tranexamic acid for bleeding during hip replacement surgery
This study tests whether a medicine called tranexamic acid (TXA), given as a shot into the hip joint or as a soak on the skin, can reduce bleeding during hip replacement surgery. It is for people over 60 who broke their hip from a simple fall and need a cementless hip replacement.
Bangkok, BangkokAges 60 years+ - NCT06081244RecruitingPhase 3
Testing sacituzumab govitecan with or without pembrolizumab for early triple-negative breast cancer
This trial tests a two-drug combination (sacituzumab govitecan and pembrolizumab) versus sacituzumab govitecan alone before surgery for low-risk, triple-negative breast cancer that hasn't spread. The goal is to see which approach works better at shrinking tumors.
Baden-Baden, Baden-WurttembergAges 18 years+
Common questions
- Are there clinical trials studying Comparator?
- Yes. Clin2 currently lists 1,730 recruiting studies that include Comparator, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Comparator trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Comparator an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Comparator or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.